La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Randomized Controlled Trials as Topic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Randomization < Randomized Controlled Trials as Topic < Randomized Controlled Trials as Topic (methods)  Facettes :

List of bibliographic references indexed by Randomized Controlled Trials as Topic

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000261 (2016) Rainer Wirth [Allemagne] ; Rainer Dziewas [Allemagne] ; Anne Marie Beck [Danemark] ; Pere Clavé [Espagne] ; Shaheen Hamdy [Royaume-Uni] ; Hans Juergen Heppner [Allemagne] ; Susan Langmore [États-Unis] ; Andreas Herbert Leischker [Allemagne] ; Rosemary Martino [Canada] ; Petra Pluschinski [Allemagne] ; Alexander Rösler [Allemagne] ; Reza Shaker [États-Unis] ; Tobias Warnecke [Allemagne] ; Cornel Christian Sieber [Allemagne] ; Dorothee Volkert [Allemagne]Oropharyngeal dysphagia in older persons – from pathophysiology to adequate intervention: a review and summary of an international expert meeting
000439 (2016) Anne-Marie A. Wills [États-Unis] ; Adriana Pérez ; Jue Wang ; Xiao Su ; John Morgan ; Suja S. Rajan ; Maureen A. Leehey ; Gregory M. Pontone [États-Unis] ; Kelvin L. Chou ; Chizoba Umeh [États-Unis] ; Zoltan Mari [États-Unis] ; James BoydAssociation Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
000450 (2016) Maribel Márquez-Cruz [Mexique] ; Juan Pablo Díaz-Martínez [Canada] ; Herman Soto-Molina [Mexique] ; Adib Jorge De Saráchaga [Mexique] ; Amin Cervantes-Arriaga [Mexique] ; Rodrigo Llorens-Arenas [Mexique] ; Mayela Rodríguez-Violante [Mexique]A systematic review and mixed treatment comparison of monotherapy in early Parkinson's disease: implications for Latin America.
000493 (2015) Marcus W. Koch [Canada] ; Lawrence Korngut [Canada] ; David G. Patry [Canada] ; Yahya Agha-Khani [Canada] ; Christopher White [Canada] ; Justyna R. Sarna [Canada] ; Michael Yeung [Canada] ; V Wee Yong [Canada] ; Daniel Y C. Heng [Canada] ; Gary Cutter [États-Unis] ; Luanne Metz [Canada]The promise of futility trials in neurological diseases.
000754 (2015) Avril Mansfield [Canada] ; Jennifer S. Wong [Canada] ; Jessica Bryce ; Svetlana Knorr ; Kara K. Patterson [Canada]Does perturbation-based balance training prevent falls? Systematic review and meta-analysis of preliminary randomized controlled trials.
000930 (2014) A J H. Moonen [Pays-Bas] ; A. Wijers [Pays-Bas] ; A F G. Leentjens [Pays-Bas] ; C W Christine [États-Unis] ; S A Factor [États-Unis] ; J. Juncos [États-Unis] ; J M Lyness [États-Unis] ; L. Marsh [États-Unis] ; M. Panisset [Canada] ; R. Pfeiffer [États-Unis] ; D. Rottenberg [États-Unis] ; C. Serrano Ramos [Porto Rico] ; L. Shulman [États-Unis] ; C. Singer [États-Unis] ; J. Slevin [États-Unis] ; W. Mcdonald [États-Unis] ; P. Auinger [États-Unis] ; I H Richard [États-Unis]Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
000A70 (2014) Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. FoxEmerging drugs for levodopa-induced dyskinesia.
000B96 (2014) Kenneth Marek [États-Unis] ; John Seibyl [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] ; Chris Hyson [Canada] ; Danna Jennings [États-Unis]Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
001508 (2012) Behzad Elahi [Canada] ; Nicolás Phielipp [Canada] ; Robert Chen [Canada]N-Methyl-D-Aspartate Antagonists in Levodopa Induced Dyskinesia: A Meta- Analysis
001787 (2011) Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
002146 (2008) V. ChatsisRotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.
002932 (2006) Andrew R. Willan [Canada] ; Ron Goeree [Canada] ; Eleanor M. Pullenayegum [Canada] ; Christopher Mcburney [États-Unis] ; Gordon Blackhouse [Canada]Economic evaluation of rivastigmine in patients with parkinson's disease dementia
002956 (2005) C. Marras [Canada] ; M P Mcdermott ; P A Rochon ; C M Tanner ; G. Naglie ; A. Rudolph ; A E LangSurvival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
002985 (2005) Stanley Fahn [États-Unis]Does levodopa slow or hasten the rate of progression of Parkinson's disease?
002B79 (2004) Ronald B. Postuma [Canada] ; Anthony E. LangHomocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
002F45 (2003) Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis
002F58 (2002) Raúl De La Fuente-Fernández [Canada] ; A Jon StoesslThe placebo effect in Parkinson's disease.
002F78 (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
003310 (2001) Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada]Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials
004A04 (1990) E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. CalneClozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis
004A20 (1989) I. Shoulson [États-Unis]Deprenyl and tocopherol antioxidative therapy of parkinsonism (DATATOP). Parkinson Study Group.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Randomized Controlled Trials as Topic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Randomized Controlled Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Randomized Controlled Trials as Topic
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022